Cargando…

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) resulting in demyelination and neurodegeneration. The therapeutic strategy is now largely based on reducing inflammation with immunosuppressive drugs. Unfortunately, when disease progression is observed, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collongues, Nicolas, Becker, Guillaume, Jolivel, Valérie, Ayme-Dietrich, Estelle, de Seze, Jérôme, Binamé, Fabien, Patte-Mensah, Christine, Monassier, Laurent, Mensah-Nyagan, Ayikoé Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338208/ https://www.ncbi.nlm.nih.gov/pubmed/35610531 http://dx.doi.org/10.1007/s40120-022-00363-7

Ejemplares similares

Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection
por: Jolivel, Valérie, et al.
Publicado: (2021)

Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera
por: El Khoury, Youssef, et al.
Publicado: (2022)

Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System
por: Venard, Christine, et al.
Publicado: (2011)

Neurosteroid 3α-Androstanediol Efficiently Counteracts Paclitaxel-Induced Peripheral Neuropathy and Painful Symptoms
por: Meyer, Laurence, et al.
Publicado: (2013)

The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
por: Metzger-Peter, Katline, et al.
Publicado: (2020)

5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer’s disease
por: Klein, Christian, et al.
Publicado: (2018)

Disruption of Sema3A/Plexin‐A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination
por: Binamé, Fabien, et al.
Publicado: (2019)

Myelin in Alzheimer’s disease: culprit or bystander?
por: Maitre, Michel, et al.
Publicado: (2023)

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis
por: Kremer, Laurent, et al.
Publicado: (2019)

A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer’s disease
por: Maitre, Michel, et al.
Publicado: (2016)

Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
por: Grimm, Amandine, et al.
Publicado: (2012)

Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment
por: Locci, Andrea, et al.
Publicado: (2017)

A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity
por: Taleb, Omar, et al.
Publicado: (2021)

Characterization of the spontaneous degenerative mitral valve disease in FVB mice
por: Ayme-Dietrich, Estelle, et al.
Publicado: (2021)

Local modulation of steroid action: rapid control of enzymatic activity
por: Charlier, Thierry D., et al.
Publicado: (2015)

H1153Y-KCNH2 Mutation Identified in a Sudden Arrhythmic Death Syndrome Case Alters Channel Gating
por: Farrugia, Audrey, et al.
Publicado: (2021)

Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
por: Grimm, Amandine, et al.
Publicado: (2015)

Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol
por: Lim, Yun-An, et al.
Publicado: (2011)

Xanthurenic Acid Binds to Neuronal G-Protein-Coupled Receptors That Secondarily Activate Cationic Channels in the Cell Line NCB-20
por: Taleb, Omar, et al.
Publicado: (2012)

Evaluation of a 5-HT(2B) receptor agonist in a murine model of amyotrophic lateral sclerosis
por: Arnoux, Alizée, et al.
Publicado: (2021)

TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis
por: Lejri, Imane, et al.
Publicado: (2019)

Chronic Bickerstaff’s encephalitis with cognitive impairment, a reality?
por: Renaud, Mathilde, et al.
Publicado: (2014)

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
por: Bigaut, Kévin, et al.
Publicado: (2021)

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
por: Clavelou, Pierre, et al.
Publicado: (2023)

Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study
por: Cobo-Calvo, Álvaro, et al.
Publicado: (2019)

Cancer control in Ghana: A narrative review in global context
por: Mensah, Kofi Boamah, et al.
Publicado: (2020)

Neurophysiological responses to unpleasant stimuli (acute electrical stimulations and emotional pictures) are increased in patients with schizophrenia
por: Duval, Céline Z., et al.
Publicado: (2016)

Inflammatory-like presentation of CADASIL: a diagnostic challenge
por: Collongues, Nicolas, et al.
Publicado: (2012)

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains
por: Combe, Roy, et al.
Publicado: (2016)

Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
por: Licht-Mayer, Simon, et al.
Publicado: (2020)

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)
por: Bigaut, Kévin, et al.
Publicado: (2019)

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020)

Diversity of Axonal and Dendritic Contributions to Neuronal Output
por: Goaillard, Jean-Marc, et al.
Publicado: (2020)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
por: Bigaut, K., et al.
Publicado: (2021)

Pharmacological Approach for Neuroprotection After Cardiac Arrest—A Narrative Review of Current Therapies and Future Neuroprotective Cocktail
por: Choudhary, Rishabh C., et al.
Publicado: (2021)

Patient perceptions of multiple sclerosis and its treatment
por: de Seze, Jérôme, et al.
Publicado: (2012)

Netrin-1 in Post-stroke Neuroprotection: Beyond Axon Guidance Cue
por: Luo, Ying, et al.
Publicado: (2022)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2litevovpildr50kg7ccmm86a2